Bristol-Myers Squibb Company Ce
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Bristol-Myers Squibb Company Ce generated cash of $13,860,000,000, which is more than the previous year. Cash used in financing activities reached the amount of -$9,416,000,000 last year. Net change in cash is therefore $2,194,000,000.
Cash Flow
| 2014 | 3.14B | 1.21B | -2.43B |
|---|---|---|---|
| 2015 | 1.83B | -1.57B | -3.35B |
| 2016 | 2.85B | 1.48B | -2.44B |
| 2017 | 5.27B | -66M | -4.07B |
| 2018 | 5.94B | -874M | -3.53B |
| 2019 | 8.06B | -9.77B | 7.62B |
| 2020 | 14.05B | -10.85B | -1.15B |
| 2021 | 16.20B | -538M | -16.22B |
| 2022 | 13.06B | -1.06B | -16.96B |
| 2023 | 13.86B | -2.29B | -9.41B |
CELG-RI Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 9.32B | 14.31B | 14.97B | 12.82B | 6.91B | 5.42B | 4.23B | 2.38B | 5.57B | 3.58B |
Operating activities | ||||||||||
Net income | 8.04B | 6.34B | 7.01B | -8.99B | 3.46B | 4.94B | 975M | 4.50B | 1.63B | 2.02B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 9.76B | 10.27B | 10.68B | 10.38B | 1.74B | 637M | 789M | 382M | 376M | 467M |
Stock-based compensation expense | 518M | 457M | 583M | 779M | 441M | 221M | 199M | 205M | 235M | 213M |
| Deferred income tax benefit | 518M | 457M | 583M | 779M | 441M | 221M | 199M | 205M | 235M | 213M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -995M | -663M | -2.11B | -2.95B | 1.65B | -267M | -431M | -803M | -942M | -252M |
Inventories | -751M | -69M | 13M | 2.67B | 463M | -216M | -29M | -152M | 97M | -254M |
Accounts payable | 198M | 109M | 245M | 188M | 229M | -59M | 320M | 104M | -919M | -44M |
Cash generated by operating activities | 13.86B | 13.06B | 16.20B | 14.05B | 8.06B | 5.94B | 5.27B | 2.85B | 1.83B | 3.14B |
Investing activities | ||||||||||
Purchases Of Investments | -1.77B | -3.59B | -5.47B | -4.17B | -3.96B | -2.30B | -5.43B | -3.08B | -3.14B | -5.71B |
Investments In Property Plant And Equipment | -1.20B | -1.11B | -973M | -753M | -836M | -951M | -1.05B | -1.21B | -820M | -526M |
Acquisitions Net | -260M | -2.98B | -862M | -12.21B | -8.78B | 3M | 14M | 975M | -403M | 3.36B |
Cash generated by investing activities | -2.29B | -1.06B | -538M | -10.85B | -9.77B | -874M | -66M | 1.48B | -1.57B | 1.21B |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 6.67B | 0 | -543M | 0 | 181M | 266M | 0 |
Payments for dividends | -4.74B | -4.63B | -4.39B | -4.07B | -2.67B | -2.61B | -2.57B | -2.54B | -2.47B | -2.39B |
Repurchases of common stock | -5.15B | -8.00B | -6.28B | -1.54B | -7.3B | -320M | -2.46B | -231M | 819M | 0 |
Repayments of term debt | 456M | -5.31B | -6.02B | -2.75B | 17.65B | -5M | 991M | -15M | -689M | -676M |
Cash used in financing activities | -9.41B | -16.96B | -16.22B | -1.15B | 7.62B | -3.53B | -4.07B | -2.44B | -3.35B | -2.43B |
Net Change In Cash | 2.19B | -4.99B | -657M | 2.15B | 5.90B | 1.49B | 1.18B | 1.85B | -3.18B | 1.98B |
Cash at end of period | 11.51B | 9.32B | 14.31B | 14.97B | 12.82B | 6.91B | 5.42B | 4.23B | 2.38B | 5.57B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |